222 related articles for article (PubMed ID: 34801046)
1. Cytotoxicity of synthetic derivatives against breast cancer and multi-drug resistant breast cancer cell lines: a literature-based perspective study.
Sharmin S; Rahaman MM; Martorell M; Sastre-Serra J; Sharifi-Rad J; Butnariu M; Bagiu IC; Bagiu RV; Islam MT
Cancer Cell Int; 2021 Nov; 21(1):612. PubMed ID: 34801046
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel 1,8-acridinediones derivatives: Investigation of MDR reversibility on breast cancer cell lines T47D and tamoxifen-resistant T47D.
Moallem SA; Dehghani N; Mehri S; Shahsavand Sh; Alibolandi M; Hadizadeh F
Res Pharm Sci; 2015; 10(3):214-21. PubMed ID: 26600848
[TBL] [Abstract][Full Text] [Related]
4. Molecular Studies on Novel Antitumor Bis 1,4-Dihydropyridine Derivatives Against Lung Carcinoma and their Limited Side Effects on Normal Melanocytes.
Mohamed MF; Ibrahim NS; Elwahy AHM; Abdelhamid IA
Anticancer Agents Med Chem; 2018; 18(15):2156-2168. PubMed ID: 30338746
[TBL] [Abstract][Full Text] [Related]
5. Anticancer effects of synthetic hexahydrobenzo [g]chromen-4-one derivatives on human breast cancer cell lines.
Pordeli M; Nakhjiri M; Safavi M; Ardestani SK; Foroumadi A
Breast Cancer; 2017 Mar; 24(2):299-311. PubMed ID: 27250840
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity and mode of action of a naturally occurring naphthoquinone, 2-acetyl-7-methoxynaphtho[2,3-b]furan-4,9-quinone towards multi-factorial drug-resistant cancer cells.
Kuete V; Mbaveng AT; Sandjo LP; Zeino M; Efferth T
Phytomedicine; 2017 Sep; 33():62-68. PubMed ID: 28887921
[TBL] [Abstract][Full Text] [Related]
7. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of ungeremine towards multi-factorial drug resistant cancer cells and induction of apoptosis, ferroptosis, necroptosis and autophagy.
Mbaveng AT; Bitchagno GTM; Kuete V; Tane P; Efferth T
Phytomedicine; 2019 Jul; 60():152832. PubMed ID: 31031043
[TBL] [Abstract][Full Text] [Related]
9. Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy.
Pu YS; Hsieh TS; Cheng AL; Tseng NF; Su IJ; Hsieh CY; Lai MK; Tsai TC
Br J Urol; 1996 Jan; 77(1):76-85. PubMed ID: 8653321
[TBL] [Abstract][Full Text] [Related]
10. Novel ceramide analogues display selective cytotoxicity in drug-resistant breast tumor cell lines compared to normal breast epithelial cells.
Crawford KW; Bittman R; Chun J; Byun HS; Bowen WD
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1017-23. PubMed ID: 14682383
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies.
Rajendra Prasad VV; Peters GJ; Lemos C; Kathmann I; Mayur YC
Eur J Pharm Sci; 2011 Jul; 43(4):217-24. PubMed ID: 21565270
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of epunctanone and four other phytochemicals isolated from the medicinal plants Garcinia epunctata and Ptycholobium contortum towards multi-factorial drug resistant cancer cells.
Mbaveng AT; Fotso GW; Ngnintedo D; Kuete V; Ngadjui BT; Keumedjio F; Andrae-Marobela K; Efferth T
Phytomedicine; 2018 Sep; 48():112-119. PubMed ID: 30195869
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of seven naturally occurring phenolic compounds towards multi-factorial drug-resistant cancer cells.
Kuete V; Mbaveng AT; Nono EC; Simo CC; Zeino M; Nkengfack AE; Efferth T
Phytomedicine; 2016 Jul; 23(8):856-63. PubMed ID: 27288921
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen and tranilast show a synergistic effect against breast cancer in vitro.
Darakhshan S; Ghanbari A; Gholami Rad F; Bidmeshki Pour A
Bratisl Lek Listy; 2015; 116(1):69-73. PubMed ID: 25666966
[TBL] [Abstract][Full Text] [Related]
15. Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds.
Kars MD; Iseri OD; Gündüz U; Ural AU; Arpaci F; Molnár J
Anticancer Res; 2006; 26(6B):4559-68. PubMed ID: 17201178
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines.
Kuete V; Sandjo LP; Ouete JL; Fouotsa H; Wiench B; Efferth T
Phytomedicine; 2014 Feb; 21(3):315-22. PubMed ID: 24075210
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of isoflavones and biflavonoids from Ormocarpum kirkii towards multi-factorial drug resistant cancer.
Adem FA; Mbaveng AT; Kuete V; Heydenreich M; Ndakala A; Irungu B; Yenesew A; Efferth T
Phytomedicine; 2019 May; 58():152853. PubMed ID: 30836216
[TBL] [Abstract][Full Text] [Related]
18. Antrodia cinnamomea extract inhibits the proliferation of tamoxifen-resistant breast cancer cells through apoptosis and skp2/microRNAs pathway.
Lin YS; Lin YY; Yang YH; Lin CL; Kuan FC; Lu CN; Chang GH; Tsai MS; Hsu CM; Yeh RA; Yang PR; Lee IY; Shu LH; Cheng YC; Liu HT; Lee KD; Chang DC; Wu CY
BMC Complement Altern Med; 2018 May; 18(1):152. PubMed ID: 29743060
[TBL] [Abstract][Full Text] [Related]
19. Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines.
Kim JH; Chung JB; Park IS; Kim BS; Yoo NC; Choi JH; Roh JK; Kim HS; Kwon OH; Lee KS
Yonsei Med J; 1993 Mar; 34(1):35-44. PubMed ID: 8397460
[TBL] [Abstract][Full Text] [Related]
20. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
